Detection of a new HIV-1 reverse transcriptase mutation (Q145M) conferring resistance to nucleoside and non-nucleoside inhibitors in a patient failing highly active antiretroviral therapy
- 1 April 2003
- journal article
- Published by Wolters Kluwer Health in AIDS
- Vol. 17 (6) , 924-927
- https://doi.org/10.1097/00002030-200304110-00022
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Drug resistance at low viraemia in HIV-1-infected patients with antiretroviral combination therapyAIDS, 2002
- Analysis of HIV drug‐resistant quasispecies in plasma, peripheral blood mononuclear cells and viral isolates from treatment‐naive and HAART patientsJournal of Medical Virology, 2001
- Human Immunodeficiency Virus Reverse Transcriptase and Protease Sequence Database: an expanded data model integrating natural language text and sequence analysis programsNucleic Acids Research, 2001
- Molecular mechanisms of HIV-1 resistance to nucleoside reverse transcriptase inhibitors (NRTIs)Cellular and Molecular Life Sciences, 2000
- The Relation between Baseline HIV Drug Resistance and Response to Antiretroviral Therapy: Re-Analysis of Retrospective and Prospective Studies Using a Standardized Data Analysis PlanAntiviral Therapy, 2000
- A Family of Insertion Mutations between Codons 67 and 70 of Human Immunodeficiency Virus Type 1 Reverse Transcriptase Confer Multinucleoside Analog ResistanceAntimicrobial Agents and Chemotherapy, 1999
- Novel Four‐Drug Salvage Treatment Regimens after Failure of a Human Immunodeficiency Virus Type 1 Protease Inhibitor–Containing Regimen: Antiviral Activity and Correlation of Baseline Phenotypic Drug Susceptibility with Virologic OutcomeThe Journal of Infectious Diseases, 1999
- Structure of a Covalently Trapped Catalytic Complex of HIV-1 Reverse Transcriptase: Implications for Drug ResistanceScience, 1998